Skip to content
Mucosis logo

Mucosis Alternatives & Competitors

7 companies similar to Mucosis — Pioneering needle-free mucosal vaccines for natural and robust immunity.

Companies similar to Mucosis

Osivax logo — alternative to Mucosis

Osivax

Pioneering A New Class of Universal Vaccines

Misti logo — alternative to Mucosis

Misti

Next-generation lung delivery to protect every vulnerable child and adult from infections

Vaxart, Inc. logo — alternative to Mucosis

Vaxart, Inc.

The pill that moves the needle.

Vaxxas logo — alternative to Mucosis

Rival Readout

Competing with Mucosis? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
X-Vax Technology logo — alternative to Mucosis

X-Vax Technology

Pioneering the future of vaccines to conquer mucosal infections and protect millions globa...

Vaxess Technologies logo — alternative to Mucosis

Vaxess Technologies

Forging a path to more convenient, self-empowered, and accessible healthcare

TheraJect, Inc. logo — alternative to Mucosis

TheraJect, Inc.

Enhancing Vaccine Efficacy and Expanding Global Access with Innovative, Needle-Free Transd...

About Mucosis

Mucosis B.V., founded in 2006, is a Dutch biotechnology company specializing in needle-free mucosal vaccines administered via the nose or mouth. Their flagship product, SynGEM®, an intranasal vaccine targeting respiratory syncytial virus infection, is based on the patented and validated Mimopath® technology. This techn...

Business keywords

Vaccines, Intranasal Delivery, Mucosal Vaccines, Respiratory Syncytial Virus, Mimopath Technology, Clinical-stage, Innovation, Needle-free Administration, Immune Response, Proof-of-concept, Dutch Company, SynGEM, FluGEM, Natural Immunity

Frequently Asked Questions

Companies similar to Mucosis include Osivax, Misti, Vaxart, Inc., Vaxxas, X-Vax Technology. They work in Biotechnology and Health Care and share Mucosis's focus on vaccines and innovation.
Bounce Watch lists 7 companies that share Mucosis's industries and are closest to it in business tags, services, target customers, business model and size.
Mucosis B.V., founded in 2006, is a Dutch biotechnology company specializing in needle-free mucosal vaccines administered via the nose or mouth. Their flagship product, SynGEM®, an intranasal vaccine targeting respiratory syncytial virus infection, is based on the patented and validated Mimopath® technology. This techn...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Mucosis: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Mucosis on 21 Jun 2024. The 7 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout